O. E. Abramova

O. E. Abramova

Auto-generated profile, based on publicly available information

O. E. Abramova

A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2023 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
OAO. E. Abramova
O. E. Abramova
DKD. V. Kudryavtsev
D. V. Kudryavtsev
AKA. A. Kurilchik
A. A. Kurilchik
SIS. A. Ivanov
S. A. Ivanov
Regional recurrences are one of the most common first manifestations of progression of clinically localized cutaneous melanoma. They are caused by subclinical metastases in the lymph nodes. Biopsy of the sentinel lymph nodes is the most effective method of detection of hidden regional metastases. It allows to appropriately increase the volume of surgical treatment prior to dissection of the affected lymph collector and perform adjuvant therapy with the most effective drugs. This, in its turn, allows for significant improvement of regional and systemic control of the disease and long-term treatment outcomes.Data obtained in several randomized trials on the effectiveness of lymph node dissection in patients with sentinel lymph node metastasis showed that this procedure significantly improves regional control of the disease but does not affect long-term treatment outcomes. Additionally, some studies showed that assignment of responsibility for regional control to adjuvant therapy does not meet the expectations. Therefore, the most effective method of regional control of cutaneous melanoma is surgery. All of these studies show that it is necessary to develop criteria for identification of patients with high risk of metastases in the non-sentinel lymph nodes who require lymph node dissection for regional disease control and creation of the best conditions for adjuvant systemic therapy. This requires identification of predictors of multiple involvement of regional lymph nodes justifying indications for radical lymph node dissection. Studies in this area are being performed but their results are ambiguous and sometimes contradictory.Aim. To evaluate the effectiveness of lymph node biopsy and radical lymph node dissection in patients with cutaneous melanoma and subclinical involvement of the sentinel lymph node.

25 December 2021 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
OAO. E. Abramova
O. E. Abramova
DKD. V. Kudryavtsev
D. V. Kudryavtsev
AKA. A. Kurilchik
A. A. Kurilchik
Introduction. Melanoma skin is a tumor with a high metastatic potential. Often, its lymphogenous spread is realized in the first place. That is why the assessment of the state of the regional zones of lymph drainage is a prognostically significant aspect of the diagnosis of this disease. The study objective – to estimate the possible predictive value of the results of preoperative lymphoscintigraphy for multiple regional lymph node involvement in clinically localized cutaneous melanoma.Materials and methods. The study involved 89 patients with clinically localized cutaneous melanoma who underwent sentinel lymph node biopsyand regional lymphadennectomy. Morphological findings were compared with the results of preoperative lymphoscintigraphy. Results. In this paper, quantitative data such as the number of lymphatic drainage areas, the number of sentinel lymph nodes in one anatomic region and their combination were considered. Conclusion. It was impossible to determine unambiguously the number of involved lymph nodes. However, the lymphoscintigraphic findings were suggestive of a higher risk for multiple lymph node involvement in patients with several accumulation zones and several lymphatic drainage areas.

16 June 2025 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
KSKirill Silakov
Kirill Silakov
OAO. E. Abramova
O. E. Abramova
ESE. V. Shako
E. V. Shako
MBM. A. Bobrov
M. A. Bobrov
PMP. A. Molotkov
P. A. Molotkov
GDGrigory Demyashkin
Grigory Demyashkin
Modern understanding of melanoma carcinogenesis and progression highlights the importance of identifying risk factors and prognosis at early stages.Purpose of the study. Analysis of clinical characteristics in patients with skin melanoma.Patients and methods. A retrospective analysis of the medical records of 142 patients with skin melanoma has been carried out. Data on age, gender, tumor localization, disease stage according to the American Joint Committee on Cancer (8th ed., 2017), histological types according to the WHO classification (2022), as well as treatment methods and disease outcomes have been analyzed.Results. Among the studied patients with skin melanoma, women predominated – 78 cases (54.9 %), men – 64 cases (45.1 %). The average age of patients was 63 ± 5.6 years, ranging from 29 to 88 years. Melanoma was most frequently diagnosed at advanced stages: stages IIIA–IIID were detected in 53 patients (37.3 %), stages IIA–IIC – in 40 (28.2 %), and stages 0 and IA–IB – in 16 (11.3 %) and 33 (23.2 %) patients, respectively. The predominant histological types were nodular melanoma (48.6 %) and superficially spreading melanoma (38.7 %). The most common tumor localizations were the skin of the lower extremities (32.3 %) and the back (30.9 %). In 23 patients (16.2 %) with disease progression, metastases were detected in the brain, lymph nodes, liver, lungs, and bones.Conclusions. The carried-out analysis can help clarify the clinical and morphological features of skin melanoma and improve diagnostic and therapeutic approaches.

1 November 2024 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
OAO. E. Abramova
O. E. Abramova
DKD V. Kudryavtsev
D V. Kudryavtsev
AKA. A. Kurilchik
A. A. Kurilchik
SIS. A. Ivanov
S. A. Ivanov
Introduction. The use of modern adjuvant drug therapy in cases of cutaneous melanoma with sentinel lymph node (LN) (SLN) metastases reduced frequency of performance of completing lymphadenectomy. However, until now, domestic and foreign clinical recommendations indicate possibility of using this procedure in patients with an unfavorable prognosis while criteria are not provided for assessing the risk of non-sentinel LN (NSLN) damage and the need to perform lymphadenectomy.Aim. To identify predictors of high risk of metastasis in NSLN in patients with cutaneous melanoma with subclinical metastases in SLN.Materials and methods. The study included 92 patients with clinically localized cutaneous melanoma (cT1–4N0M0), who showed subclinical lesions as a result of SLN biopsy, and therefore underwent a final lymphadenectomy.Results. In the examined group, 26 (28.3 %) patients, along with SLN lesions, showed metastases in NSLN. Recognition of several active LNs during radionuclide mapping of SLNs is associated with a significantly higher risk of NSLN damage – in 42.3 % vs 15.2 % in the group with radiopharmaceutical activity only in SLNs (p = 0.018). Tumors thickness of 2 mm is also associated with a high frequency of NSLN metastasis (100 % of cases). No metastasis to other LNs was observed in tumor thickness of 2 mm. In ulcerated melanomas, the incidence of NSLN lesions was 92.3 % (p = 0.02). Only subcapsular localization of SLN metastases is associated with a relatively low incidence of NSLN metastasis (13.3 % of cases) as compared with parenchymal, mixed localization, and multifocal lesion (42.9 % of cases) (p = 0.002). For SLN metastases 4 mm in size, a incidence of NSLN damage was higher than for metastases of 4 mm in size (43.3% vs 19.3%; p 0.05), as that for invasion of LN structures of 2 mm in size versus invasion of 2 mm in size (44.4% vs 15.7 %; p = 0,003). The identified predictors of NSLN involvement in practice are often combined forming a pattern of predictors. The number of prognostic parameters in the pattern has a significant effect on the incidence of NSLN lesions (0.001). In particular, the presence of 2 or less predictors is associated with low risk of metastasis in NSLN (0–12.5 % of cases), 3-5 predictors - with a relatively high risk (37.5–44.4 % of cases), 6 predictors – with a very high risk (80 % of cases).Conclusion. Recognition of predictors of metastasis in NSLN and their number allows us to decide on the need to perform final lymphadenectomy in patients with cutaneous melanoma with subclinical metastases in SLN. Conducting the final lymphadenectomy in patients with a high risk of multiple lesions of regional LNs will provide better locoregional control over stage III cutaneous melanoma and will create optimal conditions for adjuvant drug therapy.